Showing results (51-60 of 192) with videos related to

Sort By:
Pageof 20
Lupus Science & Medicine|January 30, 2015
Evaluation of B lymphocyte stimulator and a proliferation inducing ligand as candidate biomarkers in lupus nephritis based on clinical and histopathological outcome following induction therapyIoannis Parodis, Agneta Zickert, Birgitta Sundelin, et al.
Lupus Science & Medicine|January 14, 2025
Neutrophil gelatinase-associated lipocalin (NGAL) in lupus nephritis and beyondMarina Barguil Macedo, Ting Wang, Andreas Jönsen, et al.
RMD Open|July 3, 2026
Extracellular vesicles exposing complement split products are associated with kidney involvement in antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV)Anna Juto, Jelena Colic, Apostolos Taxiarchis, et al.
Arthritis and Rheumatism|March 30, 2007
Histopathologic and clinical outcome of rituximab treatment in patients with cyclophosphamide-resistant proliferative lupus nephritisIva Gunnarsson, Birgitta Sundelin, Thorunn Jónsdóttir, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 3, 2025
Characterization of autoantibody profiles in clusters of systemic lupus erythematosus using a novel autoantigen discovery technologyEurope B DiCillo, David S Pisetsky, Elisabet Svenungsson, et al.
Frontiers in Medicine|November 2, 2023
Augmented thrombin formation is related to circulating levels of extracellular vesicles exposing tissue factor and citrullinated histone-3 in anti-neutrophil cytoplasmic antibody-associated vasculitidesAsta Dogg Jonasdottir, Milena Manojlovic, Jelena Vojinovic, et al.
Arthritis Research & Therapy|August 14, 2021
First exposure to rituximab is associated to high rate of anti-drug antibodies in systemic lupus erythematosus but not in ANCA-associated vasculitisFrancesca Faustini, Nicky Dunn, Nastya Kharlamova, et al.
Clinical Immunology (Orlando, Fla.)|October 19, 2006
Treatment with rituximab affects both the cellular and the humoral arm of the immune system in patients with SLETherese Vallerskog, Iva Gunnarsson, Mona Widhe, et al.
Lupus Science & Medicine|September 14, 2022
Interleukin (IL) 16: a candidate urinary biomarker for proliferative lupus nephritisAliisa Häyry, Francesca Faustini, Agneta Zickert, et al.
Frontiers in Immunology|April 25, 2022
Rituximab in Systemic Lupus Erythematosus: Transient Effects on Autoimmunity Associated Lymphocyte Phenotypes and Implications for ImmunogenicityFrancesca Faustini, Natalie Sippl, Ragnhild Stålesen, et al.
Pageof 20